Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,580 | 11,234 | 24,703 | N/A | N/A |
| Marketable Securities | 12,995 | 12,516 | 0 | N/A | N/A |
| Other current assets | 861 | 383 | 390 | 0 | 0 |
| TOTAL | $22,436 | $24,133 | $25,093 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 189 | 166 | 109 | N/A | N/A |
| Other Non-Current Assets | 0 | 3,616 | 3,607 | 0 | 0 |
| TOTAL | $189 | $3,782 | $3,716 | $N/A | $N/A |
| Total Assets | $26,153 | $27,870 | $28,770 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 828 | 818 | 0 | 0 |
| Accrued Expenses | N/A | 475 | 475 | N/A | N/A |
| Other current liabilities | N/A | 134 | 184 | N/A | N/A |
| TOTAL | $2,053 | $1,526 | $1,573 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 18 | 0 | 0 |
| TOTAL | $N/A | $N/A | $18 | $N/A | $N/A |
| Total Liabilities | $2,053 | $1,526 | $1,591 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1,111 | 48,607 | 1,233 | N/A | N/A |
| Retained earnings | N/A | -23,065 | -21,946 | N/A | N/A |
| Other shareholders' equity | 22,990 | 802 | -204 | 0 | 0 |
| TOTAL | $24,100 | $26,344 | $27,179 | $N/A | $N/A |
| Total Liabilities And Equity | $26,153 | $27,870 | $28,770 | $0 | $0 |